Skip to content
GLP-1 Savers

Head-to-head · Value Score

REMEVi vs RxSpan MD

Two GLP-1 deals, scored on the same six factors. REMEVi lands a Value Score of 89, RxSpan MD a 86. Compare their advertised prices, billing terms, and what to check before paying.

By Grant Ashford, Founder & Pricing Editor
★ Better value

REMEVi

Grade A · Great Deal

Advertised price

$143/mo month-to-month

$143/mo month-to-month ($96/mo on the 12-month plan, compounded)

Get this deal Full REMEVi review →
VS

RxSpan MD

Grade A- · Great Deal

Advertised price

$249/mo month-to-month

$249/mo month-to-month (as low as $175/mo on the 12-month plan)

Get this deal Full RxSpan MD review →

The verdict

Better value: REMEVi

REMEVi takes it on Value Score, 89 to 86 — at an advertised price of $143/mo month-to-month ($96/mo on the 12-month plan, compounded). Check the pricing terms before enrolling. RxSpan MD isn't out of it: People who want a wide, doctor-fronted menu with all-inclusive pricing and nationwide coverage, and who will budget against the month-to-month figure rather than the advertised one.

Featured partner:CoreAge Rx, advertised prices with checkout conditions (Value Score 81).Read the review →

If neither program settles it, the Lttl review and the Belle Health review cover two other programs we partner with, and each sets out its price and billing terms so you can run the same comparison.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealREMEViRxSpan MD
Value Score89 (A)86 (A-)
Advertised price$143/mo month-to-month ($96/mo on the 12-month plan, compounded)$249/mo month-to-month (as low as $175/mo on the 12-month plan)
Save vs brand self-pay——
Semaglutide$143/mo month-to-month ($96/mo on the 12-month plan, compounded)$249/mo month-to-month (as low as $175/mo on the 12-month plan)
Tirzepatide$224/mo month-to-month ($168/mo on the 12-month plan, compounded)$329/mo month-to-month (as low as $243/mo)
Both moleculesYesYes
PricingWatchWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

Lowest Real Price
REMEVi: 82. RxSpan MD: 80.
No Teaser-Rate Bait
REMEVi: 90. RxSpan MD: 82.
Nationwide Availability
REMEVi: 96. RxSpan MD: 96.
Both Molecules
REMEVi: 98. RxSpan MD: 94.
Easy Cancellation
REMEVi: 95. RxSpan MD: 88.
Reputation
REMEVi: 87. RxSpan MD: 86.

REMEVi

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

What's good

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly in one plan table rather than used as a teaser - semaglutide is $143 monthly, $125 on 3 months, $118 on 6 and $96 on 12
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

The fine print

  • The lowest figures need a full 12-month plan: semaglutide is $96 there against $143 month-to-month, and tirzepatide $168 against $224
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

RxSpan MD

A broad, physician-led menu - compounded and oral GLP-1 plus an advertised brand-name lane under a named plastic surgeon - priced at $249 a month for semaglutide, with the advertised low rates attached to a plan.

What's good

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support in one price; cancel or change plans anytime, with the card advertising as low as $175/mo on compounded semaglutide for anyone who commits to a plan
  • Both injectable and a real oral (capsule) route, on compounded sema/tirz plus an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz, plastic surgeon); 24/7 unlimited messaging and coaching, free shipping

The fine print

  • Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy, Ozempic or Zepbound
  • RxSpan MD's brand-name lane is expensive: $1,069 for a first month of Zepbound, $1,299 for Ozempic and $1,349 for Wegovy
  • RxSpan MD's $175 and $243 rates need a 12-month plan paid up front with a promo code, and that plan auto-renews
  • Prescription isn't guaranteed at RxSpan MD — a provider reviews eligibility after checkout
Get the REMEVi deal Get the RxSpan MD deal

We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores REMEVi is ranked on the REMEVi alternatives ranking, and the same list for the other side is on alternatives to RxSpan MD.

More head-to-heads

The programs scoring closest to this pair, side by side.

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.